| RBC |
Pore-forming
toxin |
Toxin–membrane
specific interaction |
α-Hemolysin |
(5, 14−23) |
| Streptolysin O |
| Listeriolysin O |
| MRSA secreted protein |
| RBC and platelet |
Pathological
antibody |
Antibody–cell
receptor binding |
Anti-RBC
antibody |
(7) |
| Antiplatelet antibody |
(26) |
| RBC and mitochondrial
outer membrane |
Small molecule
toxicant |
Molecule–receptor
binding |
Organophosphate |
(8) |
| Anticancer compound |
(28) |
| Macrophage |
LPS |
LPS–membrane receptor
binding |
LPS |
(29) |
| Macrophage
and neutrophil |
Inflammatory
cytokine |
Cytokine–membrane
receptor binding |
IL-6 |
(10, 29) |
| IL-1β |
| TNF-α |
| T cell, macrophage, and
lung epithelial cell |
Virus |
Virus–membrane
receptor
binding |
HIV SARS-CoV-2 |
(31−33) |
| RBC and macrophage |
Enzyme |
“Lure-and-kill”
mechanism |
PLA2 |
(36, 37) |
| Gastric epithelial cell
and bacterial outer membrane |
Bacterium |
Bacterium–membrane
receptor binding |
H. pylori |
(34, 35) |